Neurosequential Model of Therapeutics (NMT) Assessment

Back to Search

Program/Intervention Name

Neurosequential Model of Therapeutics (NMT) Assessment


Assessment and Measurement Instruments for Target Populations, Staff Training and Development, Clinical Practice Model

Program/Intervention Description

The Neurosequential Model of Therapeutics (NMT). NMT is a developmentally-informed, biologically respectful approach to working with at-risk children that helps to organize a child’s history and current functioning. Especially relevant to children and youth experiencing early trauma, NMT integrates the core principles from the fields of neurodevelopment and traumatology to determine the how the timing and severity of trauma may have influenced the development of the brain. The results help professionals and families apply interventions that are appropriately aligned with the child’s needs and strengths. NMT is not a specific intervention, rather an approach to clinical work that is informed by neuroscience (Perry, 2006).

Intervention Target Population Identified (Age Group)

0-5, 6-12, 13-17, >17, Parent/Adult

Program Goals/Outcomes

NMT helps to strengthen family relationships and improves caregiver competence and confidence. The improvement results from the organization of the child’s history and current functioning that ensures that appropriate therapeutic interventions are being chosen (assessment) and education of the caregiver on how to best support the therapeutic needs of the child in their care.

QIC Target Group

General - 3

QIC Adoption/Guardianship Relevance Levels

LEVEL 6: General Population
Intervention is being evaluated in a project site

QIC level of Evidence

LEVEL 4: Promising Practice

Intervention Web Site/URL

Contact Person/Purveyor

Jana Rosenfelt, M.Ed./ Dr. Bruce Perry


The ChildTrauma Academy

Contact Email

Contact Phone

(866) 943-9779

External Links (Registry/Other Catalog)